OPTIMIZING EPO THERAPY WITH LOW-DOSE IV IRON ADMINISTRATION IN HEMODIALYSIS (HD) PATIENTS

被引：0

作者：

SUNDERPLASSMANN, G ^{[1
]}

HORL, WH ^{[1
]}

机构：

[1] UNIV VIENNA, INNERE MED KLIN 3, VIENNA, AUSTRIA

来源：

KIDNEY INTERNATIONAL | 1995年 / 47卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：998 / 998

页数：1

共 50 条

[1] OPTIMIZING LOW-DOSE RHUEPO COMBINED WITH LOW-DOSE IV IRON THERAPY IN HEMODIALYSIS-PATIENTS
UNDERPLASSMANN, G
HORL, WH
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 478 - 478
[2] Managing anemia in patients on hemodialysis: Optimizing EPO and IV iron therapy
不详
[J]. FORMULARY, 1998, 33 (10) : 1019 - 1019
[3] COMBINED IV IRON AND LOW-DOSE ERYTHROPOIETIN (RHUEPO) THERAPY IN HD-PATIENTS
TSOBANELIS, T
KURZ, P
HOPPE, D
VLACHOJANNIS, J
GRUTZMACKER, P
[J]. KIDNEY INTERNATIONAL, 1993, 44 (04) : 911 - 911
[4] LOW-DOSE SUBCUTANEOUS (SC) VS INTRAVENOUS (IV) RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS
BARCLAY, PG
FISCHER, ER
HARRIS, DCH
[J]. KIDNEY INTERNATIONAL, 1992, 42 (04) : 1046 - 1046
[5] COMBINED IV IRON AND ULTRA LOW-DOSE ERYTHROPOIETIN (RHUEPO) THERAPY IN HEMODIALYSIS-PATIENTS
TSOBANELIS, T
HOPPE, D
SCIGALLA, P
GRUTZMACHER, P
[J]. KIDNEY INTERNATIONAL, 1992, 41 (02) : 496 - 496
[6] Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin
Kurihara, I
Saito, T
Nakayama, K
Sato, H
[J]. NEPHRON, 1998, 80 (03): : 369 - 370
[7] INTRAVENOUS (IV) VS SUBCUTANEOUS (SC) ADMINISTRATION OF ERYTHROPOIETIN (EPO) IN HEMODIALYSIS (HD) PATIENTS
VIDAU, P
PERAL, V
TOME, R
RODRIGUEZ, C
HERRERA, J
[J]. KIDNEY INTERNATIONAL, 1994, 46 (02) : 571 - 571
[8] ROLE OF ENDOGENOUS ERYTHROPOIETIN (EPO) IN THE HEMATOPOIETIC RESPONSE TO IRON ADMINISTRATION IN HEMODIALYSIS (HD) PATIENTS (PTS)
MOORE, L
SMITH, SO
BURK, LB
SMITH, SJ
WILL, K
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 571 - 571
[9] Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin
Harmankaya, Ö
Eran, A
[J]. RENAL FAILURE, 2002, 24 (02) : 245 - 247
[10] THE COMPARATIVE EFFICACY OF 3 REGIMES OF IV-IRON DEXTRAN IN HEMODIALYSIS (HD) PATIENTS TREATED WITH ERYTHROPOIETIN (EPO)
SALTISSI, D
SAUVAGE, D
WESTHUYZEN, J
[J]. KIDNEY INTERNATIONAL, 1994, 46 (03) : 923 - 923

← 1 2 3 4 5 →